Chemical Structure 1 (Rytary Extended Release Capsules 1)
Rytary Capsule, Extended Release
Product Images NDC 64896-663
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rytary (NDC 64896-663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure 2 (Rytary Extended Release Capsules 2)
1 (Rytary Extended Release Capsules 3)
RYTARY (carbidopa and levodopa) is a medicine available in the form of extended-release capsules. This medication is prescribed for the treatment of movement disorders like Parkinson's disease. It contains 3.75mg/95mg of carbidopa and levodopa, respectively. It should be stored at a temperature of 25° 1T, and the container should be protected from light and moisture. RYTARY is manufactured by Bora Pharmaceutical Laboratories Inc. in Taiwan and distributed by Amneal Specialty. The lot and expiration details of the medication are provided on the packaging.*
1 (Rytary Extended Release Capsules 4)
RYTARY is an extended-release capsule medication containing carbidopa and levodopa. It should be kept in a tightly closed and light-resistant container and stored between 15°C to 30°C (59°F to 86°F). It is manufactured by Bora Pharmaceutical in Bridgewater, NJ and comes in a 100 capsules package with NDC 64896-662-01. The could not capture the text in one area mentioned as "LOT & EXP AREA", hence unable to provide the information.*
1 (Rytary Extended Release Capsules 5)
This is a description of a medication called RYTARY which comes in extended-release capsules of 48.75 mg of carbidopa and 195 mg of levodopa. The usual dosage information is contained in the package insert. The medication should be kept out of reach of children and stored in tightly closed, light-resistant containers at temperatures between 25°C and 30°C. The medication is manufactured by Bora Pharmaceutical Laboratories Inc. in Taiwan and distributed by Amneal Specialty, a division of Amneal Pharmaceuticals, based in Bridgewater, New Jersey. Each container holds 100 capsules. The lot and expiration date information is not available in the text.*
1 (Rytary Extended Release Capsules 6)
This is a medication information label for extended-release capsules containing both carbidopa and levodopa. The dosage information is not provided and must be consulted on the package insert. Each capsule contains 61.25 mg of carbidopa and 245 mg of levodopa. The medication must be kept out of children's reach in a tightly closed, light-resistant container and stored at a temperature range of 15°C to 30°C (59°F to 86°F). The drug should be protected from light and moisture. The manufacturing company is Bora Pharmaceuticals in Jhunan, Taiwan, and it is distributed in the US by Amneal Specialty in Bridgewater, NJ. It is only available with a prescription. Batch and expiration information are missing from the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
